Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding
To access this article, please choose from the options below
Dr. Critchley has received project grant funding for laboratory staff and consumables for studies evaluating uterine effects of SPRMs from TAP Pharmaceutical and Schering. She has also received expenses and lecture fees for contributing as an invited speaker. Dr. Munro is or has been a consultant to Karl Storz Endoscopy, Gynesonics, Ethicon Women's Health and Urology, Ethicon Endosurgery, Tyco Medical, ConMed, Boston Scientific, Novacept, Microsulis Americas, TAP Pharmaceuticals, JL Company, and Gyrus-ACMI. Dr. Broder has served as a consultant to TAP Pharmaceutical Products. Dr. Fraser has received lecture fees and expenses and has acted as an occasional consultant to Bayer Schering Pharma, Organon, and Daiichi.
PII: S0015-0282(07)03946-5
doi:10.1016/j.fertnstert.2007.10.060
© 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

